Methotrexate-associated lymphoproliferative disease detected as a colorectal mass lesions: a case report.
Katsudai ShirakabeKen MizokamiPublished in: Journal of surgical case reports (2023)
Methotrexate-related lymphoproliferative disorder (MTX-LPD) is a rare but serious complication that occurs in patients treated with methotrexate (MTX); although MTX-LPD has been reported recently, the incidence in the colon is very low. A 79-year-old woman who had been receiving MTX for 15 years came to our hospital complaining of postprandial abdominal pain and nausea. Computed tomography scan showed the dilation of the small bowel and a tumor in the cecum. In addition, numerous nodular lesions were seen in the peritoneum. Ileal-transverse colon bypass surgery was performed for small bowel obstruction. Histopathological findings of both the cecum and the peritoneal nodules revealed the diagnosis of MTX-LPD. We report MTX-LPD occurring in the colon; it is important to consider MTX-LPD when intestinal symptoms occur during MTX therapy.
Keyphrases
- small bowel
- computed tomography
- high dose
- abdominal pain
- epstein barr virus
- magnetic resonance imaging
- healthcare
- positron emission tomography
- emergency department
- stem cells
- type diabetes
- low dose
- risk factors
- acute coronary syndrome
- adipose tissue
- magnetic resonance
- weight loss
- mesenchymal stem cells
- diffuse large b cell lymphoma
- sleep quality
- single cell
- bone marrow
- physical activity
- blood glucose
- percutaneous coronary intervention
- surgical site infection
- chemotherapy induced